Rasaei, Niloufar
Bigdeli, Reza
Jafrasteh, Somayeh
Norouzirad, Reza
Bahadoran, Zahra
Article History
Received: 22 January 2025
Revised: 15 March 2025
Accepted: 7 April 2025
First Online: 14 April 2025
Declarations
:
: Informed consent was obtained in writing from all participants. The study protocol was approved by the ethics research committee at Dezful University of Medical Sciences, Dezful, Iran, under the approval code IR.DUMS.REC.1402.003. The trial is registered in the Iranian Registry of Clinical Trials under the identifier IRCT20240623062229 N1. The study protocol was conducted in accordance with the relevant guidelines outlined in the Declaration of Helsinki.
: The authors declare no competing interests.